Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential ...

A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could ...

The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 accompanies ...

"Eventually the hope is that it extends patients' lives but also increases the quality of their lives," study author Manish Arora told Newsweek.

There has been a breakthrough in the research on the disease amyotrophic lateral sclerosis (ALS). Scientists at Umeå University report that the disease progression in a patient with a particularly ...

BARCELONA, Spain--(BUSINESS WIRE)--The international pharmaceutical company Ferrer has announced the extension of its phase III clinical trial ADORE (ALS trial with Daily ORal Edaravone), with FNP122 ...

National Correspondent, "CBS News Sunday Morning" Lee Cowan is an Emmy-award-winning journalist serving as a national correspondent and substitute anchor for "CBS News Sunday Morning." The first time ...

Over the last decade, researchers at the University of Michigan have continued to find that exposure to environmental toxins—from pesticides used in agriculture to volatile organic compounds in the ...

TOKYO, Oct 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin(R) for Injection 25 mg" (mecobalamin) has received the Good ...